Table 3: Characteristics of index prescription among new opioid users, by prescription initiator
VariableInitiator; no. (%) of patients*Standardized difference†
Emergency physicianFamily physician
> 1 prescription dispensed217 (0.6)339 (0.7)0.01
Formulation
Long-acting87 (0.2)1048 (2.3)0.18
Short-acting34 598 (99.7)44 779 (97.4)0.19
Both28 (0.1)125 (0.3)0.05
Opioid type
2 different opioids183 (0.5)245 (0.5)0.0
1 opioid
    Combination product31 991 (92.2)41 941 (91.3)0.03
        Codeine combination20 117 (62.9)35 005 (83.5)0.48
        Oxycodone combination11 874 (37.1)6936 (16.5)0.48
    Single-agent products2539 (7.3)3766 (8.2)0.03
        Codeine328 (12.9)1563 (41.5)0.68
        Morphine804 (31.7)592 (15.7)0.38
        Fentanyl 5‡89 (2.4)> 0.1
        Oxycodone33 (1.3)394 (10.5)0.40
        Hydromorphone1128 (44.4)813 (21.6)0.50
        Meperidine241-245‡315 (8.4)< 0.1
Dosage, MEQs/d
Median (IQR)38 (25-50)19 (13-32)0.90
< 20 mg5782 (16.6)23 596 (51.3)0.79
20-49 mg19 123 (55.1)17 684 (38.5)0.34
50-99 mg8739 (25.2)4238 (9.2)0.43
100-199 mg1069 (3.1)434 (0.9)0.15

Note: IQR = interquartile range, MEQ = morphine equivalent.

*Except where noted otherwise.

†Imbalance defined as absolute value greater than 0.10 (small effect size).

‡In cases in which the number in the cell is less than 6, this number has been suppressed to ensure confidentiality. In cases in which only 1 record is being suppressed, another record has been suppressed to provide a range in order to avoid residual disclosure.